Contact Us
We are international
-select-
Italiano
Français
中文
Español
Deutsch
Русский
日本語
Türkçe
Português
한국어
Polski
Ελληνικά
עִברִית
Čeština
اللغة العربية
Norske
Danske
Nederlands
हिंदी
Afrikaans
فارسی
հայերեն
Magyar
Donate
•about myeloma
newly diagnosed?
10 steps to better care®
caregivers
publications
•treatment options
frontline therapy
novel therapies
bone disease
stem cell transplant
treatment at relapse
clinical trials
supportive care
myeloma matrix
drugs In development
•health professionals
black swan research initiative™
clinical trials
international myeloma working group
imwg conference series
nurse leadership board
asian myeloma network
global clinical trials forum
webcasts
seminars & meetings
meeting highlights
kyle lifetime achievement award
• support
toll-free hotline
support groups
online group
• webcasts
#askdrdurie
webcasts from patient & family seminars
webcasts from medical meetings
imwg conference series
nlb webcasts
imf webcasts
imf international webcasts
teleconferences
webinars
• meetings
patient & family seminars
community workshops
international seminars
event calendar
• advocacy
IMF advocacy
advocacy update
become an advocate
action center
advocate of the month
public policy statements
latest news and info
contact us
• fundraising
FUNdraisers
make a donation
major giving
planned giving
tributes and memorials
annual comedy celebration
the hope society
1000 cranes of hope
fly a virtual kite
cell phones for a cure
shop for the imf
buy imf merchandise
donate your vehicle
contact development
• media
• blogs
myeloma voices
IMF at ASH 2012
• about imf
about us
people of IMF
international partners
imf funded research
Dose-escalating & pharmacologic study of bortezomib in adult cancer pts with impaired renal function
By
IMF Admin
on
February 23, 2011 1:14 PM
|
No Comments
Dose-escalating & pharmacologic study of bortezomib in adult cancer pts with impaired renal function
Be the first to comment
Name
Email Address
URL
Remember personal info?
Comments (You may use HTML tags for style)
Discussions About IMF Web Site Content
Commented
Recent
Welcome to the International Myeloma Foundation's Blogs
Dr. Matsui - Origin of the Myeloma Stem Cell
How to Be a Good Patient
Michael Katz
ASH 2009: Mariateresa Fulciniti
Gadolinium Containing Contrast Agent Promotes Multiple Myeloma Cell Growth: Implication for Clinical Use of MRI in Myeloma
Thalidomide For Multiple Myeloma
Contact The Development Department
New! Webinar with CE Credit - Consensus on Care: Updates in the Management of Side Effects in Multiple Myeloma: A Case-Based Approach to Care
Myeloma Minute
May 17, 2010
International Myeloma Working Group at ASH 2009
THE INTERNATIONAL MYELOMA FOUNDATION SAYS NEW THALIDOMIDE DATA CONFIRMS SURVIVAL BENEFITS FOR OLDER PATIENTS
Myeloma Awareness Month 2011 ? Clinical Trials: Why they?re important and why you should consider participating in one.
March 10th
Salvatore L. Ruggiero, DMD, MD Talks About Osteonecrosis of the Jaw (ONJ)
ASH 2010 Highlights for Patients with Myeloma
ASH 2010 Multiple Myeloma Highlights for Physicians
Lori Watson
THE CATLETT CARD SERIES
ASH 2005 Webcast - Myeloma In Younger Patients
Myeloma Center Spotlight: University of Arkansas for Medical Sciences
Winter 2006 Myeloma Today in PDF
Ask the Expert:
Dr. Steve Schey Answers Your Questions
All Blogs
Most Commented
Most Recent
G-d Helps Them That Help Themselves
Welcome to the "Good Patient" Blog!
Diarrhea - Can we talk?
Watch Out For Peripheral Neuropathy!
Protect Your Stomach!
Depression
Biaxin: Beware Of Drug Interactions
Managing Steroid-Associated Side Effects
Supplements: What's The Story?
Protecting Kidney Function in Multiple Myeloma
IMF Articles
Most Commented
Most Recent
Welcome to the International Myeloma Foundation's Blogs
Dr. Matsui - Origin of the Myeloma Stem Cell
How to Be a Good Patient
Michael Katz
ASH 2009: Mariateresa Fulciniti
Gadolinium Containing Contrast Agent Promotes Multiple Myeloma Cell Growth: Implication for Clinical Use of MRI in Myeloma
Thalidomide For Multiple Myeloma
Myeloma Awareness Month 2011 ? Clinical Trials: Why they?re important and why you should consider participating in one.
March 10th
Salvatore L. Ruggiero, DMD, MD Talks About Osteonecrosis of the Jaw (ONJ)
ASH 2010 Highlights for Patients with Myeloma
ASH 2010 Multiple Myeloma Highlights for Physicians
Lori Watson
We thank our website sponsors
Amgen
Binding Site
Celgene Corporation
Genentech
GSK Oncology
Onyx Pharmaceuticals
We welcome our international partners
Canada
China
Czech Republic
Europe
Israel
Italy
Japan
Latin America
Be the first to comment